Executive Council


Paolo Decuzzi

Paolo Decuzzi earned his Ph.D. in Mechanical Engineering from the University of Naples – Federico II (IT) in 2001. 

He was then nominated in 2003 Assistant Professor of Machine Design at the Polytechnic University of Bari (IT); in 2005 Associate Professor in Mechanical Engineering in the School of Medicine of the University ‘Magna Graecia’ (IT). In 2007, he moved to The University of Texas Health Science Center in Houston (TX-USA) as an Associate Professor of Biomedical Engineering and from October 2010 thought June 2015, he served as a Professor of Biomedical Engineering and interim chair of the Translational Imaging Department at the Houston Methodist Hospital (TX-USA). With an ERC Consolidator Grant, in July 2015, he returned to Italy, joined the Italian Institute of Technology in Genova as a Senior Researcher and founded the Laboratory of Nanotechnology for Precision Medicine. 

He has published over 170 papers in international peer-reviewed journals at the interface between bioengineering and materials science, biotechnology, medicine and computational science. 

His laboratory activities focus on the rational-design of polymeric nanoconstructs for multi-modal imaging and combination therapies; fabrication of microfluidic chips for the characterization of nanomedicines; development of multi-scale, hierarchical computational models; organization of dissemination activities at the interface between engineering and biomedical sciences; and helping young scientists to develop research and leadership skills in multi-disciplinary environments.

Vice President

Francesco Cilurzo

Francesco Cilurzo is associate professor in drug delivery and regulatory affairs at University of Milan and Director of the Specialization School in Hospital Pharmacy in the same Athenaeum.

He is founder and member of the board of directors of "Pharmafilm srl- Spin-Off of the University of Milan" working on the development of orodispersible films and (trans)dermal drug delivery systems. The research activities aim to: the enhancement of passive diffusion through epidermis by supersaturation, peptide penetration enhancers and nanovectors; the design of drug eluting medical devices to reduce the restenosis risk after angioplasty; development of oromucosal formulations (mucoadhesive dosage forms and orodispersible films) in the attempt to improve pre-gastric absorption.

Furthermore, he is involved in activities on the doctrinal elaboration regards the national and UE pharmaceutical regulation related to the production and the commercialization of medicaments and health products.


Pasquale Del Gaudio

Pasquale Del Gaudio is an Associate Professor in Pharmaceutical Technology at the University of Salerno.

He graduated in Chemistry at the University of Salerno in 2001. In 2002 he was appointed an EC scholarship by Enantioselective Recognition EC Network at the University of Southampton (UK). In 2003 he moved to the  University of Parma for a Ph.D. in Biopharmaceutics-Pharmacokinetics, that he earned in 2005. From 2006 to 2018 he has been Assistant Professor in Pharmaceutical Technology at the University of Salerno. In 2018 he joined COST Association being part of the board of the AERoGELS (Advanced Engineering and Research of aeroGels for Environmental and Life Scieces) Cost Action.

His main research activities are focused on the design, development and formulations of innovative controlled release dosage forms for drugs and biomolecules; with special regards to Microencapsulation and nanoencapsulation of drugs and phytotherapics for oral controlled release dosage forms; Formulation of innovative controlled release dosage forms for the administration of drugs by alternative routes (pulmonary, loco regional and transdermal route); Design and development of medical devices for wound healing; Novel biodegradable drug delivery systems by 3D printing technologies.

He is the author of 3 patents and published over 70 papers in international peer-reviewed  journals in the pharmaceutical and biomaterial field; he has presented more than 50 personal communications at national and international symposia.


Ida Genta

Ida Genta is an Associate Professor of Pharmaceutical Technology and Law at thr University of Pavia in Italy.

Her main research lines deal with: formulative studies of micro- and nano-particulate drug delivery systems for passive and active targeting therapeutic approaches and to overcome critical issues e.g. low solubility, low bioavailability and stability of synthetic drugs, macromolecules or biotech molecules. Biopolymer physical-chemical, functional and biological characterization; chemical functionalization of polymers: polymer-polymer and polymer–drug conjugation. Cell microencapsulation for tissue regenerative purposes; synthesis of 2D and 3D biodegradable scaffolds for tissue regeneration (bone, cartilage, soft tissues) by electrospinning and 3D printing technologies. Study of the effect of gamma and beta radiations on micro-, nano-particulate delivery systems and biodegradable scaffolds. Smart parenteral formulations and medical devices.


Gennara Cavallaro

Gennara Cavallaro obtained her PhD in Chemical Sciences from the University of Palermo in 1994. In 1998 she was nominated assistant professor of Pharmaceutical Chemistry and Technology (University of Palermo), and she became full professor of Pharmaceutical Technologies at the University of Palermo in 2006.

Her main research activities focus on the synthesis, physicochemical and biological characterization of biocompatible materials having a polymeric, oligosaccharide or lipid structure and systems derived from them, which are used mainly in the field of controlled and targeted release of biologically active substances (drugs, genes, proteins) (Drug Delivery Systems and Targeting - DDST) and in the field of tissue engineering. However, the main expertise of Professor Gennara Cavallaro focuses on the chemistry of natural (i.e. polysaccharides, peptides, proteins) and synthetic polymers (polyaminoacids, polyesters, polyamides, polyanhydrides), on the most advanced procedures for the functionalization of such materials and on the technological processes that allow their transformation into systems with size ranging from the nanoscale (nanoparticles, nanogel, surfactants and polymeric micelles, interpolyelectrolitic complexes with DNA), to microparticles, to hydrogels (biodegradable, stimulus sensitive, intelligent), and to three-dimensional scaffolds for cell growth (films, sponges, fibrillar scaffold).

Professor Cavallaro is co-author of about 170 article publications and 9 national and international patents.


Giuseppe Colombo

Graduated in Pharmacy (University of Milan) in 1994. Involved in pre-formulation, formulation development and scale-up/industrialization of different pharmaceutical dosage forms (liquid, semi-solids, solid, parenterals) with particular expertise in the field of small volume injectable formulations, disperse systems and lyophilized products. 

Worked for several companies (Farmitalia-CarloErba, Pharmacia & Upjohn, Pfizer, Nerviano Medical Sciences) with different roles (from lab technician to scientist and lab manager). Currently Pharmaceutical Development Director at Italfarmaco SpA (Milan-Italy).

Member of CRS (Controlled Release Society) Italy chapter and International, AFI (Associazione Farmaceutici dell’ Industria), AAPS (American Association of Pharmaceutical Scientists) and PDA (Parenteral Drug Association) and author of several patents and scientific publications/congress presentations. Invited teacher at graduate and post-graduate courses in several Italian Universities on specific topics such as lyophilization, disperse systems, Investigational Medicinal Products and Technology Transfer.


Nadia Passerini

Nadia Passerini is Associate Professor of Pharmaceutical Technology at the Alma Mater Studiorum-University of Bologna (Italy). She obtained the Degree in Pharmaceutical Chemistry and Technology at the University of Bologna in 1992 and the PhD in Pharmaceutical Science in 1997. In 1998 Nadia won a one-year post-doctoral fellowship (Marie Curie Grant) at School of Pharmacy, University of London (UK) working in the group of Prof. D. Craig. From 1999 to 2014 she was lecturer in Pharmaceutical Technology at the University of Bologna. 

Her research focus on the study of drug delivery systems, developing new technologies and new apparatus for the production of solid dosage forms (microparticles, granules and tablets) which can optimize the biovailability of drugs according to the specific needs of the therapy. Furthermore, she is interested in the solid state characterization (DSC, HSM, FT-IR, XRD, SEM) of the obtained drug delivery systems to correlate their physicochemical properties to the in vitro release of drugs. Currently her research focus on the formulation, production and characterization of microparticles producted by the spray congealing technology, on the development and optimization of granulation and coating processes and on the development of pediatric formulations. Nadia is author of over 80 international peer reviewed publications/book chapters and over 50 contributions (poster or oral presentations) to national and international conferences.


Massimo Pedrani

Massimo Pedrani is the founder and general manager of Mogon Pharmaceuticals (Switzerland), leading provider of drug delivery system solutions with a broad range of technology platforms. Massimo has technical know-how in the field of pre-formulations, physical pharmacy, and formulations as well as professional experience in multinational and international companies including Midy (Sanofi Group), Pierrel (Fermenta Group), Farmitalia Carlo Erba (Erbamont Group), AAI Italy, Emmepi-Pharma Italy,Bigamr Inc. and Cosmo Pharmaceuticals.

He patented 4 platform technologies and 4 additional products. 


Chiara Sinico

Chiara Sinico is member of the research group of Technology for Drug Delivery at the University of Cagliari, Department of Life and Environment Sciences, Section of Drug Sciences. 

She received her Master Degree in Pharmaceutical Chemistry and Technology (1990) from the University of Cagliari and followed a post graduate internship at the University of Milan (1990-91). She became assistant professor (1993), associate professor (2011) and full professor (2019) in Pharmaceutical Technology at the University of Cagliari. 

Her research activity deals with the study of vesicular carriers as delivery systems for dermal and transdermal administration of drug, natural molecules and herbal extracts. She was also involved in preparation, characterization and evaluation study on magnetoliposomes. Recent studies focus on nanocrystals as tool for improving drug bioavailability.

Chiara Sinico is author of 90 peer-reviewed papers, 3 book chapters, 1 patent several invited lectures/seminars and supervisor of 3 PhD students.

She is member of ADRITELF and of the executive board of Controlled Release Society (Italy Chapter) and Società Farmaceutica del Mediteranneo Latino (Italian Group)

Codice Fiscale: 97487430155
Sede legale: c/o AFI via Ranzoni, 1 - 20149 Milano
This email address is being protected from spambots. You need JavaScript enabled to view it.
© Controlled Release Society Italy Local Chapter. All Rights Reserved.